These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31089384)

  • 1. Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial.
    Shidfar F; Mousavi SN; Lorvand Amiri H; Agah S; Hoseini S; Hajimiresmail SJ
    Iran J Pharm Res; 2019; 18(1):496-505. PubMed ID: 31089384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
    Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
    Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial.
    Tutunchi H; Naeini F; Saghafi-Asl M; Farrin N; Monshikarimi A; Ostadrahimi A
    Health Promot Perspect; 2020; 10(4):373-382. PubMed ID: 33312933
    [No Abstract]   [Full Text] [Related]  

  • 4. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease.
    Farzin L; Asghari S; Rafraf M; Asghari-Jafarabadi M; Shirmohammadi M
    Int J Vitam Nutr Res; 2020 Jun; 90(3-4):279-289. PubMed ID: 30789808
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
    Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
    Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Rezaei S; Tabrizi R; Nowrouzi-Sohrabi P; Jalali M; Shabani-Borujeni M; Modaresi S; Gholamalizadeh M; Doaei S
    Front Pharmacol; 2021; 12():732496. PubMed ID: 34803681
    [No Abstract]   [Full Text] [Related]  

  • 8. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease.
    Rahimpour Z; Hoseini R; Behpour N
    BMC Gastroenterol; 2022 Aug; 22(1):372. PubMed ID: 35927637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
    Lorvand Amiri H; Agah S; Mousavi SN; Hosseini AF; Shidfar F
    Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial.
    Dabbaghmanesh MH; Danafar F; Eshraghian A; Omrani GR
    Diabetes Metab Syndr; 2018 Jul; 12(4):513-517. PubMed ID: 29588137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent and Combined Effects of Calcium and Vitamin D Supplementation on Blood Lipids in Overweight or Obese Premenopausal Women: A Triple-Blind Randomized Controlled Clinical Trial.
    Rajaie H; Rabiee MR; Bellissimo N; Faghih S
    Int J Prev Med; 2021; 12():52. PubMed ID: 34447494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial.
    Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Yaseri M; Hosseinzadeh-Attar MJ
    Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):345-353. PubMed ID: 34860705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet.
    Mousavi SN; Faghihi A; Motaghinejad M; Shiasi M; Imanparast F; Amiri HL; Shidfar F
    Biol Trace Elem Res; 2018 Feb; 181(2):288-295. PubMed ID: 28577233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD).
    Ghaffari A; Rafraf M; Navekar R; Sepehri B; Asghari-Jafarabadi M; Ghavami SM
    Int J Vitam Nutr Res; 2019 Nov; 89(5-6):293-302. PubMed ID: 31017556
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial.
    Musazadeh V; Dehghan P; Khoshbaten M
    Eur J Gastroenterol Hepatol; 2022 May; 34(5):537-545. PubMed ID: 35421019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin D supplementation on various parameters in non-alcoholic fatty liver disease patients.
    Hussain M; Iqbal J; Malik SA; Waheed A; Shabnum S; Akhtar L; Saeed H
    Pak J Pharm Sci; 2019 May; 32(3 Special):1343-1348. PubMed ID: 31551213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD).
    Foroughi M; Maghsoudi Z; Askari G
    Iran J Nurs Midwifery Res; 2016; 21(1):100-4. PubMed ID: 26985230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers.
    Sharifi N; Amani R; Hajiani E; Cheraghian B
    Exp Biol Med (Maywood); 2016 Apr; 241(8):830-8. PubMed ID: 26811103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial.
    Ekhlasi G; Kolahdouz Mohammadi R; Agah S; Zarrati M; Hosseini AF; Arabshahi SS; Shidfar F
    J Res Med Sci; 2016; 21():106. PubMed ID: 28250783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.